dexamethasone,daratumumab,lenalidomide
janssen
['maia', 'mmsm']
"median time to worsening" is an odd way to analyze pros, but for palliative strategy like maia it works. longer maintained (not improved!) physical fxn is also significant from #gerionc standpoint. #ash22 #mmsm 2/ 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????